Medical treatment of benign insulinoma using octreotide LAR: A case report

Endocrine Journal

Volumn 54, Issue 1, 2007, Pages 95-101

  Usukura, Mikiya ^a   Yoneda, Takashi ^a   Oda, Nobushige ^a   Yamamoto, Yasuhiro ^a   Takata, Hiroyuki ^a   Hasatani, Kenkou ^b   Takeda, Yoshiyu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b Division of Dermatology   (Japan)

Author keywords

Insulinoma; Medical treatment; Octreotide LAR

Indexed keywords

C PEPTIDE; IMMUNOREACTIVE INSULIN; OCTREOTIDE;

AGED; ARTICLE; CASE REPORT; DRUG FORMULATION; FEMALE; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULINOMA; LABORATORY TEST; PANCREAS TUMOR; RADIODIAGNOSIS; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BLOOD GLUCOSE; DELAYED-ACTION PREPARATIONS; FEMALE; HEMOGLOBINS; HUMANS; HYPOGLYCEMIA; INSULIN; INSULINOMA; OCTREOTIDE; PANCREATIC NEOPLASMS;

EID: 33947582266     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K05-157     Document Type: Article

References (18)

1. Maton PN, Gardner JD, Jensen RT (1989) Use of longacting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumor. Dig Dis Sci 34 (Suppl 3): 28S-39S.
2. Stehouwer CDA, Lems WF, Fischer HRA, Hackeng WHL, Naafs MAB (1989) Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin). Acta Endocrinol (Copenh) 121: 34-40.
3. Tanaka Y, Funahashi H, Imai T, Naruse T, Suzumura K, Oda Y (2000) The effectiveness of administering a minimal dose of octreotide long-term prior to surgery for insulinoma: Report of a case. Surg Today 30: 541-543.
4. Hearn PR, Ahmed M, Woodhouse NJY (1988) The use of SMS 201-995 (somatostatin analogue) in insulinomas: Additional case report and literature review. Hormone Res 29: 211-213.
5. Glaser B, Roesler A, Halperin Y (1990) Chronic treatment of a benign insulinoma using the long-acting somatostatin analogue SMS 201-995. Isr J Med Sci 26: 16-19.
6. Craig CEH, Gallen IW (2002) Possible functional regression of insulinoma with prolonged octreotide. Postgrad Med J 78: 623-624.
7. Katabami T, Kato H, Shirai N, Naito S, Saito N (2005) Successful long-term treatment with once-daily injection of low-dose octreotide in an aged patient with insulinoma. Endocr J 52: 629-634.
8. Colao A, Ferone D, Marzullo P, Cappabianca P, Cirillo S, Boerlin V, Lancranjan I, Lombardi G (2001) Longterm effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab 86: 2779-2786.
9. Bertherat J, Tenenmaum F, Perlemoine K, Videau C, Alberini JL, Richard B, Dousset B, Bertagna X, Epelbaum J (2003) Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: An in vivo and in vitro study. J Clin Endocrinol Metab 88: 5353-5360.
10. Perry RR, Vinik AI (1995) Diagnosis and management of functioning islet cell tumors. J Clin Endocrinol Metab 80: 2273-2278.
11. Kondo T, Tomita S, Adachi H, Motoshima H, Taketa K, Matsuyoshi A, Tokunaga H, Miyamura N, Araki E (2005) A case of hyperinsulinemia of undetermined origin, successfully treated with long-acting octreotide. Endocr J 52: 511-517.
12. Brunt LM, Veldhuis JD, Dilley WG, Farndon JR, Santen RJ, Leight GS, Wells SA (1986) Stimulation of insulin secretion by a rapid intravenous calcium infusion in patients with β-cell neoplasms of the pancreas. J Clin Endocrinol Metab 62: 210-216.
13. Komoto I, Kato M, Itami A, Shimada Y, Doi R, Hosotani R, Imamura M (2003) Expression and function of the calcium-sensing receptor in pancreatic islets and insulinoma cells. Pancreas 26:178-184.
14. Squires PE (2000) Non-Ca2+-homeostatic functions of the extracellular Ca2+-sensing receptor (CaR) in endocrine tissues. J Endocrinol 165: 173-177.
15. Reisine T, Bell GI (1995) Molecular biology of somatostatin receptors. Endocr Rev 16: 427-442.
16. Novotny J, Janku F, Mares P, Petruzelka L (2005) Symptomatic control of hypoglycemia with prednisone in refractory metastatic pancreatic insulinoma. Support Care Cancer Jun 16; [Epub ahead of print].
17. Moscetti L, Saltarelli R, Giuiiani R, Fornarini G, Bezzi M, Cortesi E (2000) Intra-arterial liver chemotherapy and hormone therapy in malignant insulinoma: Case report and review of literature. Tumori 86: 475-479.
18. Romeo S, Milione M, Gatti A, Fallarino M, Corleto V, Morano S, Baroni MG (2006) Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year old woman with a malignant insulinoma positive for somatostatin receptors type 2. Horm Res 65: 120-125.